These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 438117)

  • 1. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus.
    Robinson JM; Hardman JK; Sloan GL
    J Bacteriol; 1979 Mar; 137(3):1158-64. PubMed ID: 438117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysostaphin endopeptidase resistance gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus.
    DeHart HP; Heath HE; Heath LS; LeBlanc PA; Sloan GL
    Appl Environ Microbiol; 1995 Apr; 61(4):1475-9. PubMed ID: 7747966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-encoded lysostaphin endopeptidase resistance of Staphylococcus simulans biovar staphylolyticus.
    Heath HE; Heath LS; Nitterauer JD; Rose KE; Sloan GL
    Biochem Biophys Res Commun; 1989 May; 160(3):1106-9. PubMed ID: 2730641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus.
    Sugai M; Fujiwara T; Ohta K; Komatsuzawa H; Ohara M; Suginaka H
    J Bacteriol; 1997 Jul; 179(13):4311-8. PubMed ID: 9209049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.
    Gargis SR; Heath HE; LeBlanc PA; Dekker L; Simmonds RS; Sloan GL
    Appl Environ Microbiol; 2010 Oct; 76(20):6944-6. PubMed ID: 20729317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus.
    Thumm G; Götz F
    Mol Microbiol; 1997 Mar; 23(6):1251-65. PubMed ID: 9106216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: Adverse influence of Zn
    Chandra Ojha S; Imtong C; Meetum K; Sakdee S; Katzenmeier G; Angsuthanasombat C
    Protein Expr Purif; 2018 Nov; 151():106-112. PubMed ID: 29944958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.
    Gründling A; Schneewind O
    J Bacteriol; 2006 Apr; 188(7):2463-72. PubMed ID: 16547033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wall-associated processing of extracellular enzymes of Staphylococcus simulans biovar staphylolyticus.
    Bunn WJ; Heath HE; LeBlanc PA; Sloan GL
    FEMS Microbiol Lett; 1998 Aug; 165(1):123-7. PubMed ID: 9711848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and some properties of lysostaphin, a glycylglycine endopeptidase from the culture liquid of Staphylococcus simulans biovar staphylolyticus.
    Fedorov TV; Surovtsev VI; Pletnev VZ; Borozdina MA; Gusev VV
    Biochemistry (Mosc); 2003 Jan; 68(1):50-3. PubMed ID: 12693976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity.
    Boksha IS; Lavrova NV; Grishin AV; Demidenko AV; Lyashchuk AM; Galushkina ZM; Ovchinnikov RS; Umyarov AM; Avetisian LR; Chernukha MIu; Shaginian IA; Lunin VG; Karyagina AS
    Biochemistry (Mosc); 2016 May; 81(5):502-10. PubMed ID: 27297900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient adsorption of lysostaphin on bacterial cells of lysostaphin-resistant Staphylococcus aureus mutant.
    Sakurada J; Murai M; Zhijun L; Usui A; Seki K; Kobayashi K; Sumi Y; Jitsukawa H; Masuda S
    Microbiol Immunol; 1993; 37(1):29-34. PubMed ID: 8474355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile penetration of the Staphylococcus aureus capsule by lysostaphin.
    King BF; Biel ML; Wilkinson BJ
    Infect Immun; 1980 Sep; 29(3):892-6. PubMed ID: 7429637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.
    Zygmunt WA; Browder HP; Tavormina PA
    Appl Microbiol; 1968 Aug; 16(8):1168-73. PubMed ID: 5675508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 19. Conserved loop residues-Tyr
    Charoenjotivadhanakul S; Sakdee S; Imtong C; Li HC; Angsuthanasombat C
    Biochem Biophys Res Commun; 2023 Aug; 668():111-117. PubMed ID: 37245291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Lif, the lysostaphin immunity factor, on acceptors of surface proteins and cell wall sorting efficiency in Staphylococcus carnosus.
    Strauss A; Thumm G; Götz F
    J Bacteriol; 1998 Sep; 180(18):4960-2. PubMed ID: 9733703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.